Defendant

Mylan N.V.

1 case as defendant.

Cases
1
Active
0
1 closed
Filed
2017
Top venue
D. New Jersey
1 case

Celgene Corp. v. Hetero Labs Ltd. et al.

terminated
Docket:
2:17-cv-03387
Filed:
2017-05-11
Terminated:
2021-08-19
Patents:8828427
π Celgene Corp.Δ Hetero Labs Ltd.Δ Hetero Labs Ltd. Unit-VΔ Hetero Drugs Ltd.Δ Hetero USA, Inc.Δ Aurobindo Pharma Ltd.Δ Aurobindo Pharma USA, Inc.Δ Aurolife Pharma LLCΔ Eugia Pharma Specialties Ltd.Δ Apotex Inc.Δ Apotex Corp.Δ Mylan Pharmaceuticals, Inc.Δ Mylan Inc.Δ Mylan N.V.Δ Breckenridge Pharmaceutical, Inc.

Hatch-Waxman ANDA litigation. The '427 was expressly named among the patents-in-suit, but Celgene withdrew its '427 infringement claims. Consolidated/coordinated for claim construction with 17-cv-03159. Case terminated 2021-08-19.